LTFS
NBRV

Ladenburg Thalmann Financial Services’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
8
– – ﹤0.01% 5021
2019
Q3 		$4K Hold
8
– – ﹤0.01% 4817
2019
Q2 		$5K Hold
8
– – ﹤0.01% 4744
2019
Q1 		$5K Hold
8
– – ﹤0.01% 4703
2018
Q4 		$3K Hold
8
– – ﹤0.01% 4828
2018
Q3 		$5K Buy
+8
New +$5.67K ﹤0.01% 4635

Other funds holding NBRV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NBRV Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its Nabriva Therapeutics plc Ordinary Shares Ireland (NBRV) position steady in Q4 2019 at 8 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #5021.

Ladenburg Thalmann Financial Services first reported a position in NBRV in Q3 2018 and has held it in 6 quarters since. The position peaked at $5K in Q2 2019. 50 funds tracked by Wall St. Rank hold NBRV as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 8 shares of Nabriva Therapeutics plc Ordinary Shares Ireland worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its Nabriva Therapeutics plc Ordinary Shares Ireland share count unchanged in Q4 2019.
  • Nabriva Therapeutics plc Ordinary Shares Ireland made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5021 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Nabriva Therapeutics plc Ordinary Shares Ireland in Q3 2018 and has held it in 6 quarters since.
  • Ladenburg Thalmann Financial Services's Nabriva Therapeutics plc Ordinary Shares Ireland position peaked at $5K in Q2 2019.
  • 50 funds tracked by Wall St. Rank held Nabriva Therapeutics plc Ordinary Shares Ireland as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.